Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	29,253	25,787	30,501	42,839	13,330	18,553
Market Cap Growth	10.75%	-15.46%	-28.80%	221.38%	-28.15%	-59.50%
Enterprise Value	28,729	24,904	28,797	76,028	47,878	54,483
Last Close Price	2.11	1.86	2.20	3.09	2.68	3.73
PE Ratio	114.47	251.53	-	5.41	-	-
Forward PE	-	2.56	2.56	2.56	2.56	2.56
PS Ratio	5.61	5.29	7.30	10.32	2.46	1.62
PB Ratio	4.15	3.64	4.37	4.30	-1.28	0.90
P/TBV Ratio	4.41	4.00	4.83	4.64	-	1.20
P/FCF Ratio	-	-	1006.12	18.27	7.70
P/OCF Ratio	-	-	199.99	12.92	6.44
PEG Ratio	0.53	0.53	0.53	0.53	0.53	0.53
EV/Sales Ratio	5.51	5.11	6.89	18.31	8.85	4.76
EV/EBITDA Ratio	47.89	50.72	-	-	-	-
EV/EBIT Ratio	103.48	121.27	-	-	-	-
EV/FCF Ratio	-57.14	-	-	1785.59	65.62	22.62
Debt / Equity Ratio	0.03	0.04	0.04	0.02	-2.09	1.60
Debt / EBITDA Ratio	0.36	0.47	-	-	-	-
Debt / FCF Ratio	-	-	-	4.82	29.78	13.67
Asset Turnover	0.36	0.33	0.27	0.17	0.11	0.17
Inventory Turnover	1.60	1.54	1.26	0.91	1.57	0.32
Quick Ratio	0.78	0.86	0.82	1.00	0.54	0.54
Current Ratio	1.43	1.46	1.36	1.68	0.80	1.69
Return on Equity (ROE)	3.71%	1.47%	-31.78%	-	-607.26%	-19.91%
Return on Assets (ROA)	1.21%	0.87%	-4.17%	-7.71%	-34.21%	-1.55%
Return on Capital (ROIC)	2.41%	1.76%	-7.46%	-17.72%	-51.60%	-1.85%
Return on Capital Employed (ROCE)	3.00%	2.10%	-	-	-	-
Earnings Yield	0.87%	0.40%	-8.81%	18.48%	-233.19%	-25.12%
FCF Yield	-1.72%	-1.62%	-2.62%	0.10%	5.47%	12.98%
Payout Ratio	0.00%	-	-	0.17%	-	-
Buyback Yield / Dilution	-0.03%	27.54%	-1.85%	-0.55%	-179.83%	20.41%
Total Shareholder Return	-0.03%	27.54%	-1.85%	-0.55%	-179.83%	20.41%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.